Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.

Berger M, Oyeyemi D, Olurinde MO, Whitson HE, Weinhold KJ, Woldorff MG, Lipsitz LA, Moretti E, Giattino CM, Roberts KC, Zhou J, Bunning T, Ferrandino M, Scheri RP, Cooter M, Chan C, Cabeza R, Browndyke JN, Murdoch DM, Devinney MJ, Shaw LM, Cohen HJ, Mathew JP; INTUIT Investigators.

J Am Geriatr Soc. 2019 Jan 23. doi: 10.1111/jgs.15770. [Epub ahead of print]

PMID:
30674067
2.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
3.

The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.

Kazaure HS, Thomas S, Scheri RP, Stang MT, Roman SA, Sosa JA.

Surgery. 2019 Jan;165(1):242-249. doi: 10.1016/j.surg.2018.03.026. Epub 2018 Oct 14.

PMID:
30327186
4.

Reply: Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.

Scheri RP, Anderson KL, Thomas SM, Stang MT, Roman SA, Sosa JA.

Surgery. 2018 Jun;163(6):1325-1329. doi: 10.1016/j.surg.2018.02.007. No abstract available.

PMID:
29859613
5.

Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".

Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

Ann Surg. 2018 Apr;267(4):e78-e79. doi: 10.1097/SLA.0000000000002161. No abstract available.

PMID:
29517563
6.

Impact of Micro- and Macroscopically Positive Surgical Margins on Survival after Resection of Adrenocortical Carcinoma.

Anderson KL Jr, Adam MA, Thomas SM, Youngwirth L, Stang MT, Scheri RP, Roman SA, Sosa JA.

Ann Surg Oncol. 2018 May;25(5):1425-1431. doi: 10.1245/s10434-018-6398-5. Epub 2018 Mar 2.

PMID:
29500765
7.

Transcriptional profiling reveals distinct classes of parathyroid tumors in PHPT.

Koh J, Hogue JA, Roman SA, Scheri RP, Fradin H, Corcoran DL, Sosa JA.

Endocr Relat Cancer. 2018 Apr;25(4):407-420. doi: 10.1530/ERC-17-0470.

PMID:
29475894
8.

Pediatric thyroid cancer patients referred to high-volume facilities have improved short-term outcomes.

Youngwirth LM, Adam MA, Thomas SM, Roman SA, Sosa JA, Scheri RP.

Surgery. 2018 Feb;163(2):361-366. doi: 10.1016/j.surg.2017.09.042. Epub 2017 Nov 22.

PMID:
29174431
9.

Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.

Anderson KL Jr, Thomas SM, Adam MA, Pontius LN, Stang MT, Scheri RP, Roman SA, Sosa JA.

Surgery. 2018 Jan;163(1):157-164. doi: 10.1016/j.surg.2017.04.028. Epub 2017 Nov 6.

PMID:
29122321
10.

Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.

Pontius LN, Oyekunle TO, Thomas SM, Stang MT, Scheri RP, Roman SA, Sosa JA.

Thyroid. 2017 Nov;27(11):1408-1416. doi: 10.1089/thy.2017.0306. Epub 2017 Oct 5.

PMID:
28891405
11.

Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: A case-control study.

Hoffman K, Lorenzo A, Butt CM, Hammel SC, Henderson BB, Roman SA, Scheri RP, Stapleton HM, Sosa JA.

Environ Int. 2017 Oct;107:235-242. doi: 10.1016/j.envint.2017.06.021.

PMID:
28772138
12.

Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Weber TJ, Koh J, Thomas SM, Hogue JA, Scheri RP, Roman SA, Sosa JA.

Metabolism. 2017 Sep;74:22-31. doi: 10.1016/j.metabol.2017.06.004. Epub 2017 Jun 19.

13.

Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes.

Anderson K Jr, Ruel E, Adam MA, Thomas S, Youngwirth L, Stang MT, Scheri RP, Roman SA, Sosa JA.

Am J Surg. 2017 Nov;214(5):914-919. doi: 10.1016/j.amjsurg.2017.07.018. Epub 2017 Jul 17.

PMID:
28736060
14.

Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults.

Giattino CM, Gardner JE, Sbahi FM, Roberts KC, Cooter M, Moretti E, Browndyke JN, Mathew JP, Woldorff MG, Berger M; MADCO-PC Investigators.

Front Syst Neurosci. 2017 May 8;11:24. doi: 10.3389/fnsys.2017.00024. eCollection 2017.

15.

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.

Beasley GM, Hu Y, Youngwirth L, Scheri RP, Salama AK, Rossfeld K, Gardezi S, Agnese DM, Howard JH, Tyler DS, Slingluff CL Jr, Terando AM.

Ann Surg Oncol. 2017 Sep;24(9):2728-2733. doi: 10.1245/s10434-017-5883-6. Epub 2017 May 15.

PMID:
28508145
16.

Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?

Shah SA, Adam MA, Thomas SM, Scheri RP, Stang MT, Sosa JA, Roman SA.

Thyroid. 2017 Jun;27(6):762-772. doi: 10.1089/thy.2016.0626. Epub 2017 Apr 19.

PMID:
28294040
17.

Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?

Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

Ann Surg. 2017 Feb;265(2):402-407. doi: 10.1097/SLA.0000000000001688.

PMID:
28059969
18.

Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.

Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA.

J Clin Oncol. 2016 Dec 20;34(36):4415-4420. Epub 2016 Oct 28.

19.

Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer.

Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA.

Thyroid. 2017 May;27(5):626-631. doi: 10.1089/thy.2016.0132. Epub 2016 Oct 5.

PMID:
27597378
20.

Lymphovascular invasion is associated with survival for papillary thyroid cancer.

Pontius LN, Youngwirth LM, Thomas SM, Scheri RP, Roman SA, Sosa JA.

Endocr Relat Cancer. 2016 Jul;23(7):555-62. doi: 10.1530/ERC-16-0123. Epub 2016 Jun 17.

PMID:
27317633
21.

T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?

Anderson KL Jr, Youngwirth LM, Scheri RP, Stang MT, Roman SA, Sosa JA.

Thyroid. 2016 Aug;26(8):1046-52. doi: 10.1089/thy.2016.0073. Epub 2016 Jul 6.

22.

Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma.

Jillard CL, Youngwirth L, Scheri RP, Roman S, Sosa JA.

Thyroid. 2016 Jul;26(7):959-64. doi: 10.1089/thy.2016.0246. Epub 2016 Jun 6.

PMID:
27150319
23.

Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome.

Adam MA, Goffredo P, Youngwirth L, Scheri RP, Roman SA, Sosa JA.

Surgery. 2016 Jan;159(1):41-50. doi: 10.1016/j.surg.2015.04.056. Epub 2015 Oct 2.

PMID:
26435426
24.

Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer.

Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA.

Ann Surg Oncol. 2016 Feb;23(2):403-9. doi: 10.1245/s10434-015-4867-7. Epub 2015 Sep 28.

PMID:
26416710
25.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

26.

A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.

Englum BR, Pura J, Reed SD, Roman SA, Sosa JA, Scheri RP.

World J Surg. 2015 Dec;39(12):2928-34. doi: 10.1007/s00268-015-3192-4.

PMID:
26324158
27.

What Is the Optimal Treatment of Papillary Thyroid Cancer?

Jillard CL, Scheri RP, Sosa JA.

Adv Surg. 2015;49:79-93. doi: 10.1016/j.yasu.2015.03.007. Epub 2015 May 1. Review. No abstract available.

PMID:
26299491
28.

Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.

Adam MA, Choudhury K, Dinan MA, Reed SD, Scheri RP, Blazer DG 3rd, Roman SA, Sosa JA.

Ann Surg. 2015 Aug;262(2):372-7. doi: 10.1097/SLA.0000000000001055.

PMID:
26158612
29.

Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care.

Goffredo P, Jillard C, Thomas S, Scheri RP, Sosa JA, Roman S.

Endocrine. 2016 Jan;51(1):123-30. doi: 10.1007/s12020-015-0649-z. Epub 2015 Jun 16.

PMID:
26077949
30.

Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.

Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA.

J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.

PMID:
26077238
31.

Impact of delayed lymphoscintigraphy for sentinel lymphnode biopsy for breast cancer.

Wang H, Heck K, Pruitt SK, Wong TZ, Scheri RP, Georgiade GS, Ichite I, Hwang ES.

J Surg Oncol. 2015 Jun;111(8):931-4. doi: 10.1002/jso.23915. Epub 2015 May 7.

PMID:
25953313
32.

Thyroid carcinoma, version 2.2014.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680.

PMID:
25505208
33.

Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.

Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

J Clin Endocrinol Metab. 2015 Jan;100(1):115-21. doi: 10.1210/jc.2014-3039.

34.

Hyperparathyroid crisis due to asymmetric parathyroid hyperplasia with a massive ectopic parathyroid gland.

Gratian LF, Hyland KA, Scheri RP.

Endocr Pract. 2014 Oct;20(10):e180-2. doi: 10.4158/EP14136.CR.

PMID:
24936566
35.

Detection and management of cervical lymph nodes in papillary thyroid cancer.

Elfenbein DM, Scheri RP, Roman S, Sosa JA.

Expert Rev Endocrinol Metab. 2013 Jul;8(4):365-378. doi: 10.1586/17446651.2013.811839.

PMID:
30736153
36.

Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project.

Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP.

J Surg Res. 2013 Sep;184(1):216-20. doi: 10.1016/j.jss.2013.04.014. Epub 2013 Apr 28.

PMID:
23664532
37.

Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy.

Salama AK, de Rosa N, Scheri RP, Pruitt SK, Herndon JE 2nd, Marcello J, Tyler DS, Abernethy AP.

PLoS One. 2013;8(3):e57665. doi: 10.1371/journal.pone.0057665. Epub 2013 Mar 13.

38.

Multidisciplinary care of patients with early-stage breast cancer.

Lyman GH, Baker J, Geradts J, Horton J, Kimmick G, Peppercorn J, Pruitt S, Scheri RP, Hwang ES.

Surg Oncol Clin N Am. 2013 Apr;22(2):299-317. doi: 10.1016/j.soc.2012.12.005. Epub 2013 Jan 3. Review.

PMID:
23453336
39.

Tumor-induced osteomalacia masking primary hyperparathyroidism.

Elfenbein DM, Weber TJ, Scheri RP.

Surgery. 2012 Dec;152(6):1256-8. doi: 10.1016/j.surg.2012.08.062. No abstract available.

PMID:
23158192
40.

The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost.

Salama AK, Rosa Nd, Scheri RP, Herndon JE, Tyler DS, Marcello J, Pruitt SK, Abernethy AP.

Cancer Invest. 2012 Nov;30(9):637-41. doi: 10.3109/07357907.2012.726387. Epub 2012 Sep 28.

PMID:
23020583
41.

Tumor proximity to the recurrent laryngeal nerve in patients with primary hyperparathyroidism undergoing parathyroidectomy.

Untch BR, Adam MA, Danko ME, Barfield ME, Dixit D, Scheri RP, Olson JA.

Ann Surg Oncol. 2012 Nov;19(12):3823-6. doi: 10.1245/s10434-012-2495-z. Epub 2012 Jul 31.

PMID:
22847120
42.

An acrochordon-like melanoma metastasis.

Kollitz KM, Tcheung WJ, Scheri RP, Selim MA, Nelson KC.

Arch Dermatol. 2012 Jan;148(1):136-7. doi: 10.1001/archdermatol.2011.1105. No abstract available.

PMID:
22250257
43.

Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years.

Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, Leight GS Jr, Olson JA Jr.

J Am Coll Surg. 2011 Apr;212(4):522-9; discussion 529-31. doi: 10.1016/j.jamcollsurg.2010.12.038.

44.

Sonography in the identification of calciphylaxis of the breast.

Bukhman R, Scheri RP, Selim MA, Baker JA.

J Ultrasound Med. 2010 Jan;29(1):129-33. No abstract available.

PMID:
20040786
45.

Importance of sentinel lymph node biopsy in patients with thin melanoma.

Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R, Morton DL.

Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900. doi: 10.1001/archsurg.143.9.892.

46.

Targeted suppression of beta-catenin blocks intestinal adenoma formation in APC Min mice.

Foley PJ, Scheri RP, Smolock CJ, Pippin J, Green DW, Drebin JA.

J Gastrointest Surg. 2008 Aug;12(8):1452-8. doi: 10.1007/s11605-008-0519-6. Epub 2008 Jun 3.

PMID:
18521697
47.

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

Scheri RP, Essner R, Turner RR, Ye X, Morton DL.

Ann Surg Oncol. 2007 Oct;14(10):2861-6. Epub 2007 Jul 18.

PMID:
17882497
48.

Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?

Morton DL, Scheri RP, Balch CM.

Ann Surg Oncol. 2007 Sep;14(9):2437-9. Epub 2007 Jun 17. No abstract available.

PMID:
17574500
49.

Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.

Torisu-Itakura H, Lee JH, Scheri RP, Huynh Y, Ye X, Essner R, Morton DL.

Clin Cancer Res. 2007 Jun 1;13(11):3125-32.

50.

Lymphatic mapping and sentinel node analysis: current concepts and applications.

Chen SL, Iddings DM, Scheri RP, Bilchik AJ.

CA Cancer J Clin. 2006 Sep-Oct;56(5):292-309; quiz 316-7. Review.

Supplemental Content

Loading ...
Support Center